Fiche publication
Date publication
septembre 2009
Auteurs
Membres identifiés du Cancéropôle Est :
Pr CORMIER Luc
,
Pr PEIFFERT Didier
Tous les auteurs :
Boudrant G, Mangin P, Feuillu B, Peiffert D, Cormier L
Lien Pubmed
Résumé
AIM: The treatment of prostate cancer using high intensity focused ultrasound (HIFU) is considered to be mini-invasive and normally has a low rate of morbidity. The aim of this study was to evaluate the quality of life of patients treated with HIFU. PATIENTS AND METHOD: Fifty consecutive patients whose first-line treatment was with HIFU for localized cancer of the prostate between 2003 and 2005 received the "UCLA/RAND PCI" quality of life questionnaire at preoperative stage and one year after treatment. The scores for postoperative quality of life were compared to preoperative scores and to a test population who did not have prostate cancer. RESULTS: Eighty percent of patients answered both questionnaires. 72.5% of the patients were "satisfied" or "very satisfied", 2.5% were "very dissatisfied" and 25% had no opinion. The general quality of life scores (SF-36) did not show any significant differences before and after treatment. Alterations and discomfort concerning sexual and urinary functions were statistically significant. For the digestive function, there was no difference before and after treatment; however, an increase in discomfort felt was statistically significant. CONCLUSION: The treatment of prostate cancer using HIFU is accepted well by the patient, quality of life is preserved one year later. There is significant degradation of the sexual function and more moderately of the urinary function.
Référence
Prog Urol. 2009 Sep;19(8):542-52
